When further resources are available, we wish to apply the strategy described for imaging and therapy of breast cancer to the targeting of brain glioblastoma tumours using a variety of antibody fragments with tumour specificity, combined with glucose and/or folic acid coatings. The ability of EIT to image brain events is illustrated in the Figure which shows the detection of epileptic episodes in two different individuals.
Epileptic fits imaged by EIT technology
Other applications could include early diagnosis of dyslexia and early discrimination between haemorrhagic and ischaemic stroke. (***Richard – do you want this in?***).
Richard Bayford | Professor of Biomodelling & Bioinformatics |
Andrew Tizzard | Reader in Bio-Engineering |
Martina Callaghan | Senior Research Fellow in Physics |
K. Ashkan | Consultant Neurosurgeon, King’s College Hospital, London |